(Q35907005)

11 August 2017

1 reference

title

Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes (English)

1 reference

11 August 2017

1 reference

2

George S Eisenbarth

1 reference

11 August 2017

Anita Azam

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Expert Opinion on Biological Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

10

1 reference

11 August 2017

page(s)

1569-1575

1 reference

The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Type 1 diabetes: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Early Infant Feeding and Risk of Developing Type 1 Diabetes–Associated Autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Heat shock protein therapy fails to prevent diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Successful islet transplantation: continued insulin reserve provides long-term glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Islet transplantation as a treatment for diabetes - a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Consequences on beta-cell function and reserve after long-term pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.10.1569

10.1517/14712598.4.10.1569

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference